AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CRH PLC

Transaction in Own Shares Nov 8, 2022

Preview not available for this file type.

Download Source File

author: Odetola, Alexander-GB+
date: 2022-11-07 17:37:00+00:00


8th November 2022 8th November 2022
CRH plc Transaction in Own Shares CRH plc Transaction in Own Shares CRH plc Transaction in Own Shares CRH plc Transaction in Own Shares  
CRH plc ('CRH') announces that on 7th November 2022 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin, from CRH’s broker UBS. The ordinary shares purchased will be held as treasury shares. CRH plc ('CRH') announces that on 7th November 2022 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin, from CRH’s broker UBS. The ordinary shares purchased will be held as treasury shares. CRH plc ('CRH') announces that on 7th November 2022 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin, from CRH’s broker UBS. The ordinary shares purchased will be held as treasury shares. CRH plc ('CRH') announces that on 7th November 2022 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin, from CRH’s broker UBS. The ordinary shares purchased will be held as treasury shares. CRH plc ('CRH') announces that on 7th November 2022 it purchased the following number of its ordinary shares (the 'ordinary shares') on Euronext Dublin, from CRH’s broker UBS. The ordinary shares purchased will be held as treasury shares.
         
      Euronext Dublin  
Number of ordinary shares purchased: Number of ordinary shares purchased: Number of ordinary shares purchased: 1,584  
Highest price paid per share: Highest price paid per share:   €36.7900  
Lowest price paid per share: Lowest price paid per share:   €36.4850  
Volume weighted average price paid: Volume weighted average price paid: Volume weighted average price paid: €36.6329  
The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million* in the period to 16th December 2022 following its announcement on 20th September 2022 and were effected by CRH's broker as part of the Programme announced on 20th September 2022. The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million* in the period to 16th December 2022 following its announcement on 20th September 2022 and were effected by CRH's broker as part of the Programme announced on 20th September 2022. The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million* in the period to 16th December 2022 following its announcement on 20th September 2022 and were effected by CRH's broker as part of the Programme announced on 20th September 2022. The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million* in the period to 16th December 2022 following its announcement on 20th September 2022 and were effected by CRH's broker as part of the Programme announced on 20th September 2022. The purchases form part of CRH's intention to buy back ordinary shares of up to $300 million* in the period to 16th December 2022 following its announcement on 20th September 2022 and were effected by CRH's broker as part of the Programme announced on 20th September 2022.
Following settlement of the above transactions CRH will hold 25,571,207 of its ordinary shares in treasury which represents 3.303% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 748,569,131 ordinary shares in issue (excluding treasury shares). Following settlement of the above transactions CRH will hold 25,571,207 of its ordinary shares in treasury which represents 3.303% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 748,569,131 ordinary shares in issue (excluding treasury shares). Following settlement of the above transactions CRH will hold 25,571,207 of its ordinary shares in treasury which represents 3.303% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 748,569,131 ordinary shares in issue (excluding treasury shares). Following settlement of the above transactions CRH will hold 25,571,207 of its ordinary shares in treasury which represents 3.303% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 748,569,131 ordinary shares in issue (excluding treasury shares). Following settlement of the above transactions CRH will hold 25,571,207 of its ordinary shares in treasury which represents 3.303% of the issued ordinary share capital of CRH. Ordinary shares held in treasury do not have any voting rights. Following settlement, CRH will have 748,569,131 ordinary shares in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement. In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made on 7th November 2022 by UBS on behalf of CRH as part of the buyback programme is scheduled to this announcement.
*Being an amount equal to €300 million (based on a FX rate of €1:$1 fixed for the duration of the buyback programme) *Being an amount equal to €300 million (based on a FX rate of €1:$1 fixed for the duration of the buyback programme) *Being an amount equal to €300 million (based on a FX rate of €1:$1 fixed for the duration of the buyback programme) *Being an amount equal to €300 million (based on a FX rate of €1:$1 fixed for the duration of the buyback programme) *Being an amount equal to €300 million (based on a FX rate of €1:$1 fixed for the duration of the buyback programme)
Contact
Diarmuid Enright
Assistant Company Secretary Assistant Company Secretary
Tel: 00 3531 6344340 Tel: 00 3531 6344340
Transaction Details Transaction Details        
Issuer name: Issuer name: CRH plc    
LEI   549300MIDJNNTH068E74 549300MIDJNNTH068E74  
ISIN:   IE0001827041 IE0001827041  
Intermediary name: Intermediary name: UBS Europe SE UBS Europe SE  
Intermediary code: Intermediary code: 5299007QVIQ7IO64NX37 5299007QVIQ7IO64NX37  
Time zone:   BST    
Currency:   EUR    
Date of Transactions: Date of Transactions: 07/11/2022    
Aggregated Information Aggregated Information        
Trading venue Trading venue Currency Volume Weighted Average Price Aggregated volume
Euronext Dublin (XMSM) Euronext Dublin (XMSM) EUR 36.6329 1,584
Euronext Dublin
Number of
Shares Price per Share (EUR) Currency Trade Time Trading Venue MatchID
280 36.49 EUR 08:02:21 Euronext Dublin (XMSM) 1681149
271 36.53 EUR 08:05:08 Euronext Dublin (XMSM) 1685308
245 36.62 EUR 08:09:02 Euronext Dublin (XMSM) 1693427
243 36.60 EUR 08:09:03 Euronext Dublin (XMSM) 1693489
193 36.79 EUR 08:12:38 Euronext Dublin (XMSM) 1698973
50 36.79 EUR 08:12:38 Euronext Dublin (XMSM) 1698971
42 36.79 EUR 08:12:38 Euronext Dublin (XMSM) 1698969
195 36.78 EUR 08:12:49 Euronext Dublin (XMSM) 1699236
65 36.78 EUR 08:12:49 Euronext Dublin (XMSM) 1699234

Talk to a Data Expert

Have a question? We'll get back to you promptly.